CLINICAL EXPERIENCE WITH ETANERCEPT IN THE TREATMENT OF PATIENTS WITH ANKYLOSING SPONDYLITIS

Etanercept (ETC), a soluble tumor necrosis factor-α (TNF-α) receptor, was registered for the treatment of spondyloarthritis in the Russian Federation in 2009. By now, results of prolonged treatment with this drug have been obtained in patients with ankylosing spondylitis (AS).Objective: to evaluate...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: O. A. Rumyantseva, A. G. Bochkova, M. M. Urumova, T. V. Dubinina, Sh. F. Erdes
Format: Artigo
Idioma:Russo
Publicat: IMA-PRESS LLC 2018-05-01
Col·lecció:Научно-практическая ревматология
Matèries:
etanercept
ankylosing spondylitis
axial spondyloarthritis
remission
Accés en línia:https://rsp.mediar-press.net/rsp/article/view/2524
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars